InvestorsHub on MSN
Ambry Genetics launches whole genome sequencing tests to improve rare disease diagnosis
Ambry Genetics, a wholly owned subsidiary of Tempus AI (NASDAQ:TEM), has introduced GenomeNext and GenomeReveal, a new whole ...
AI-designed proteins improved targeted DNA insertion in cultured cells, with one variant doubling the performance of an ...
In a way, sequencing DNA is very simple: There's a molecule, you look at it, and you write down what you find. You'd think it would be easy—and, for any one letter in the sequence, it is. The problem ...
A propensity score-matched study of 403 patients finds targeted and metagenomic next-generation sequencing statistically ...
Discover how flexible, high-quality workflows can help labs scale next-generation sequencing with greater efficiency ...
Michigan Tech's Genomic Sequencing Lab, part of the University's Health Research Institute, plays a leading role in tracking animal-borne illnesses in the Upper Peninsula region while also advancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results